Evaluation of Glycemic Control and Cost Savings Associated With Liraglutide Dose Reduction at a Veterans Affairs HospitalOctober 7, 2020Diabetes
Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020DiabetesCardiologyNephrology
AHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020DiabetesCardiology
Geriatric patients: My three rules for themOctober 1, 2020StrokeMixed TopicsGeriatricsNeurologyCardiologyDiabetes
Novel calculator predicts cancer risk in patients with CVDSeptember 15, 2020Mixed TopicsDiabetesCardiologyOncology
More U.S. states cap insulin cost, but activists will ‘fight harder’September 9, 2020DiabetesBusiness of Medicine
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effectsAugust 30, 2020DiabetesCardiology
